Massachusetts General Hospital
Clinical trials sponsored by Massachusetts General Hospital, explained in plain language.
-
Promising combo trial for prostate cancer halted early
Disease control TerminatedThis study tested a combination of two drugs—tivozanib and enzalutamide—in men with advanced prostate cancer that had stopped responding to standard hormone therapy. The goal was to see if adding tivozanib (which cuts off the tumor's blood supply) to enzalutamide could delay canc…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 03:00 UTC
-
Promising MDS drug trial stopped early – what happened?
Disease control TerminatedThis study tested a drug called MBG453 in 10 people with lower-risk myelodysplastic syndromes (MDS), a bone marrow disorder. The goal was to see if the drug could improve blood cell counts and reduce the need for blood transfusions. The trial was terminated early, so results are …
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 02:51 UTC
-
Could a simple gas stop COVID-19 from getting worse?
Disease control TerminatedThis study tested whether breathing in nitric oxide gas could keep people with mild or moderate COVID-19 from getting sick enough to need a breathing tube. Researchers enrolled 62 hospitalized adults who were still breathing on their own. The trial was stopped early, so results a…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Radiation boost for CAR t fails to launch: pilot study terminated
Disease control TerminatedThis small pilot study tested whether adding radiation therapy could help CAR T-cell treatment work better in people with lymphoma that did not respond to CAR T alone. Only 3 participants were enrolled before the study was stopped early. The main goal was to check safety and side…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Lymphoma drug combo shows promise in early trial
Disease control TerminatedThis study tested a combination of two drugs, umbralisib and rituximab, as the first treatment for people with follicular lymphoma or marginal zone lymphoma. The goal was to see how many patients had their cancer completely disappear. The study was stopped early and included 18 a…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Apr 24, 2026 16:19 UTC
-
Could a simple gas shield healthcare workers from COVID-19?
Prevention TerminatedThis study aimed to see if breathing in nitric oxide gas could protect healthcare workers from catching COVID-19 while caring for infected patients. It planned to enroll 470 workers but was stopped early with only 24 participants. The main goal was to compare how many people in t…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Prevention
Last updated May 20, 2026 11:54 UTC
-
Restless legs drug may ease opioid withdrawal symptoms
Symptom relief TerminatedThis study tested whether pramipexole, a drug for restless legs syndrome, could reduce symptoms of both restless legs and opioid withdrawal in people recovering from opioid use disorder. The goal was to help them feel better and stay in treatment. The study was planned for 75 adu…
Phase: PHASE2, PHASE3 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 26, 2026 02:55 UTC
-
Promising PANDAS painkiller trial fizzles out
Symptom relief TerminatedThis study aimed to see if naproxen sodium, a common anti-inflammatory drug, could reduce obsessive-compulsive symptoms in children with PANDAS, a condition linked to strep infections. The trial planned to enroll children aged 6 to 15 with new-onset OCD, but was terminated early …
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 26, 2026 02:53 UTC
-
Chill out: new device aims to make skin needling Pain-Free
Symptom relief TerminatedThis study tested a new cooling device to see if it could reduce pain during a skin treatment called radio-frequency microneedling. Six healthy women took part, and researchers measured their pain levels after different cooling times. The study was stopped early, so results are l…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 26, 2026 02:52 UTC
-
Could a blood pressure drug improve pain relief from opioids?
Symptom relief TerminatedThis study looked at whether adding guanfacine (a blood pressure medication) to morphine could reduce pain sensitivity and tolerance in people with chronic neck or back pain. It involved 137 adults who had not taken opioids recently. The study was terminated early, so results are…
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 26, 2026 02:45 UTC
-
Study tests drug to ease opioid side effect
Symptom relief TerminatedThis small study looked at whether adding guanfacine to opioid painkillers could reduce the extra pain sensitivity that sometimes develops with long-term opioid use. It involved 8 adults with chronic neck or back pain who were already taking opioids. The study was stopped early, …
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 22, 2026 14:01 UTC
-
Autism social trial halted: memantine study falls short
Symptom relief TerminatedThis study tested whether memantine, a medication for memory, could improve social skills in youth aged 8-18 with autism or nonverbal learning disorder. The trial was stopped early after enrolling only 25 participants. Researchers measured social improvement using clinician ratin…
Phase: PHASE3 • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 22, 2026 13:52 UTC
-
Laser therapy tested for tough scars and scleroderma
Symptom relief TerminatedThis study tested a laser treatment to improve thick scars and scleroderma, a condition that hardens the skin. Researchers wanted to see if the laser could help the skin heal and look better. Only 6 people took part, and the study was stopped early, so results are limited.
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 22, 2026 13:52 UTC
-
Zapping the brain to save memories: a small study on TMS and Alzheimer's
Knowledge-focused TerminatedThis study tested whether a non-invasive brain stimulation technique called TMS could improve memory in older adults with mild cognitive impairment or early Alzheimer's disease. Only 4 people took part before the study was stopped. Researchers used brain scans to see if stimulati…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 03:01 UTC
-
Lung vs. heart: which breathing setting wins for ARDS?
Knowledge-focused TerminatedThis study looked at two different ways to set a breathing machine for people with severe lung injury (ARDS). The goal was to see which method helps lungs work better and puts less strain on the heart. Only 2 people took part before the study was stopped early, so results are ver…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 02:57 UTC
-
Smart band tracks COVID-19 breathing trouble
Knowledge-focused TerminatedThis study tested a special band called AirGo that monitors breathing in COVID-19 patients with respiratory failure. The goal was to see if the band could detect early signs of worsening breathing. The study included 25 adults hospitalized with COVID-19 who were breathing on thei…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC
-
Pain relief study halted: researchers seek to understand spinal stimulation
Knowledge-focused TerminatedThis study aimed to understand how paresthesia-free spinal cord stimulation (PF-SCS) relieves chronic pain and affects sensation. Researchers planned to enroll 10 adults already using PF-SCS for chronic pain. The study was terminated early, so results are limited.
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC
-
Brain zapping study seeks clues to childhood OCD
Knowledge-focused TerminatedThis study looked at how a gentle brain stimulation technique called tDCS affects thinking and behavior in children aged 10-17 with obsessive-compulsive disorder (OCD). The goal was to understand brain processes linked to OCD, not to treat it. The study was stopped early and incl…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC
-
Healthy volunteers breathe thin air to unlock Body's oxygen secrets
Knowledge-focused TerminatedThis study looked at how healthy adults react to breathing air with less oxygen for several days. Researchers measured oxygen levels in the blood, red blood cell production, and lung pressure to understand the body's response. The goal was to learn about safety and basic body cha…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC
-
Space brain boost: new platform aims to keep astronauts sharp on long missions
Knowledge-focused TerminatedThis study tested a personalized system that uses biosensors to adjust the work environment and help astronauts stay focused and perform well during long spaceflights. About 80 healthy adults aged 18 to 64 took part. The goal was to see if the platform could improve thinking and …
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 11, 2026 20:40 UTC